Get the Stockscreener App
532.60
1.54%
8.09
After Hours:
532.44
-0.16
-0.03%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Microsoft Corp stock is traded at $532.60, with a volume of 18.08M.
It is up +1.54% in the last 24 hours and up +3.18% over the past month.
Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).
See More
Previous Close:
$524.51
Open:
$527.4
24h Volume:
18.08M
Relative Volume:
0.93
Market Cap:
$3.95T
Revenue:
$318.27B
Net Income/Loss:
$125.22B
P/E Ratio:
31.72
EPS:
16.79
Net Cash Flow:
$72.92B
1W Performance:
-0.17%
1M Performance:
+3.18%
6M Performance:
+25.43%
1Y Performance:
+1.72%
1-Day Range:
$521.69
$533.25
1-Week Range:
$515.70
$534.21
52-Week Range:
$349.20
$553.72
Microsoft Corp Stock (MSFT) Company Profile
Name
Microsoft Corp
Sector
Industry
Phone
425-882-8080
Address
ONE MICROSOFT WAY, REDMOND, WA
Compare MSFT vs PLTR, ORCL, PANW, CRWD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MSFT
Microsoft Corp
|
532.60 | 3.95T | 318.27B | 125.22B | 72.92B | 16.79 |
PLTR
Palantir Technologies Inc
|
198.84 | 477.82B | 5.22B | 2.29B | 2.69B | 0.8876 |
ORCL
Oracle Corp
|
126.06 | 382.15B | 67.36B | 17.31B | -23.69B | 5.8248 |
PANW
Palo Alto Networks Inc
|
390.46 | 319.40B | 10.61B | 842.80M | 3.79B | 1.2157 |
CRWD
Crowdstrike Holdings Inc
|
261.83 | 268.10B | 5.09B | -24.89M | 1.43B | -0.0471 |
Microsoft Corp Stock (MSFT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-05-26 | Upgrade | Melius | Hold → Buy |
| Sep-30-26 | Reiterated | Piper Sandler | Overweight |
| Sep-23-26 | Upgrade | Stifel | Hold → Buy |
| Sep-22-26 | Reiterated | Oppenheimer | Outperform |
| Sep-21-26 | Reiterated | Cantor Fitzgerald | Overweight |
| Sep-04-26 | Reiterated | Stifel | Hold |
| Sep-01-26 | Reiterated | BofA Securities | Buy |
| Aug-12-26 | Reiterated | Wells Fargo | Overweight |
| Jul-30-26 | Reiterated | BMO Capital Markets | Outperform |
| Jul-27-26 | Reiterated | UBS | Buy |
| Jul-21-26 | Resumed | Morgan Stanley | Overweight |
| Jul-20-26 | Initiated | CLSA | Outperform |
| Jul-10-26 | Reiterated | Argus | Buy |
| Jun-01-26 | Initiated | Citizens | Mkt Outperform |
| Apr-30-26 | Reiterated | BMO Capital Markets | Outperform |
| Apr-30-26 | Reiterated | Barclays | Overweight |
| Apr-30-26 | Reiterated | Bernstein | Outperform |
| Apr-30-26 | Reiterated | Citigroup | Buy |
| Apr-30-26 | Reiterated | Deutsche Bank | Buy |
| Apr-30-26 | Reiterated | Evercore ISI | Outperform |
| Apr-30-26 | Reiterated | Piper Sandler | Overweight |
| Apr-30-26 | Reiterated | Stifel | Hold |
| Apr-30-26 | Reiterated | The Benchmark Company | Buy |
| Apr-30-26 | Reiterated | Truist | Buy |
| Apr-30-26 | Reiterated | Wells Fargo | Overweight |
| Apr-28-26 | Reiterated | BMO Capital Markets | Outperform |
| Apr-21-26 | Reiterated | Citigroup | Buy |
| Apr-15-26 | Reiterated | Robert W. Baird | Outperform |
| Apr-14-26 | Reiterated | Mizuho | Outperform |
| Apr-14-26 | Reiterated | Piper Sandler | Overweight |
| Mar-25-26 | Reiterated | UBS | Buy |
| Mar-24-26 | Resumed | BofA Securities | Buy |
| Feb-09-26 | Downgrade | Melius | Buy → Hold |
| Feb-05-26 | Downgrade | Stifel | Buy → Hold |
| Feb-03-26 | Resumed | Piper Sandler | Overweight |
| Jan-29-26 | Reiterated | BMO Capital Markets | Outperform |
| Jan-29-26 | Reiterated | Barclays | Overweight |
| Jan-29-26 | Reiterated | Bernstein | Outperform |
| Jan-29-26 | Reiterated | Citigroup | Buy |
| Jan-29-26 | Reiterated | Deutsche Bank | Buy |
| Jan-29-26 | Reiterated | Evercore ISI | Outperform |
| Jan-29-26 | Reiterated | Goldman | Buy |
| Jan-29-26 | Reiterated | JP Morgan | Overweight |
| Jan-29-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-29-26 | Reiterated | Piper Sandler | Overweight |
| Jan-29-26 | Reiterated | Robert W. Baird | Outperform |
| Jan-29-26 | Reiterated | Stifel | Buy |
| Jan-29-26 | Reiterated | Wedbush | Outperform |
| Jan-29-26 | Reiterated | Wells Fargo | Overweight |
| Jan-26-26 | Reiterated | Stifel | Buy |
| Jan-23-26 | Reiterated | UBS | Buy |
| Jan-21-26 | Reiterated | Citigroup | Buy |
| Jan-21-26 | Reiterated | Mizuho | Outperform |
| Jan-12-26 | Reiterated | Barclays | Overweight |
| Jan-12-26 | Resumed | Goldman | Buy |
| Jan-08-26 | Reiterated | Wells Fargo | Overweight |
| Nov-18-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Nov-14-25 | Initiated | Robert W. Baird | Outperform |
| Oct-30-25 | Reiterated | BMO Capital Markets | Outperform |
| Oct-27-25 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-22-25 | Reiterated | Citigroup | Buy |
| Oct-17-25 | Reiterated | Mizuho | Outperform |
| Oct-06-25 | Reiterated | Wells Fargo | Overweight |
| Jul-31-25 | Reiterated | BMO Capital Markets | Outperform |
| Jul-31-25 | Reiterated | Barclays | Overweight |
| Jul-31-25 | Reiterated | Bernstein | Outperform |
| Jul-31-25 | Reiterated | BofA Securities | Buy |
| Jul-31-25 | Reiterated | Jefferies | Buy |
| Jul-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-31-25 | Reiterated | Mizuho | Outperform |
| Jul-31-25 | Reiterated | Morgan Stanley | Overweight |
| Jul-31-25 | Reiterated | Oppenheimer | Outperform |
| Jul-31-25 | Reiterated | TD Cowen | Buy |
| Jul-31-25 | Reiterated | UBS | Buy |
| Jul-31-25 | Reiterated | Wedbush | Outperform |
| Jul-31-25 | Reiterated | Wells Fargo | Overweight |
| Jul-22-25 | Reiterated | Citigroup | Buy |
| Jul-16-25 | Reiterated | Cantor Fitzgerald | Overweight |
| Jul-16-25 | Reiterated | Mizuho | Outperform |
| Jul-09-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-02-25 | Reiterated | DA Davidson | Buy |
| Jun-25-25 | Reiterated | Wedbush | Outperform |
| Jun-11-25 | Reiterated | Citigroup | Buy |
| May-01-25 | Reiterated | BMO Capital Markets | Outperform |
| May-01-25 | Reiterated | Barclays | Overweight |
| May-01-25 | Reiterated | Evercore ISI | Outperform |
| May-01-25 | Reiterated | Goldman | Buy |
| May-01-25 | Reiterated | JP Morgan | Overweight |
| May-01-25 | Reiterated | Mizuho | Outperform |
| May-01-25 | Reiterated | Piper Sandler | Overweight |
| May-01-25 | Reiterated | RBC Capital Mkts | Outperform |
| May-01-25 | Reiterated | Raymond James | Outperform |
| May-01-25 | Reiterated | Scotiabank | Sector Outperform |
| May-01-25 | Reiterated | Stifel | Buy |
| May-01-25 | Reiterated | Wedbush | Outperform |
| Apr-17-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-16-25 | Reiterated | BMO Capital Markets | Outperform |
| Apr-16-25 | Reiterated | Morgan Stanley | Overweight |
| Apr-14-25 | Reiterated | UBS | Buy |
| Apr-14-25 | Reiterated | Wells Fargo | Overweight |
| Mar-20-25 | Initiated | Scotiabank | Sector Outperform |
| Mar-13-25 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-17-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-25 | Reiterated | Piper Sandler | Overweight |
| Oct-31-24 | Reiterated | BMO Capital Markets | Outperform |
| Oct-10-24 | Reiterated | Goldman | Buy |
| Oct-08-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-23-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-10-24 | Initiated | New Street | Buy |
| Jun-07-24 | Reiterated | Oppenheimer | Outperform |
| Apr-17-24 | Reiterated | Wells Fargo | Overweight |
| Apr-12-24 | Reiterated | BMO Capital Markets | Outperform |
| Apr-11-24 | Reiterated | Morgan Stanley | Overweight |
| Mar-21-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Jan-18-24 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Dec-13-23 | Initiated | Truist | Buy |
| Dec-05-23 | Initiated | China Renaissance | Buy |
| Oct-26-23 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-17-23 | Initiated | Loop Capital | Buy |
| Sep-25-23 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-15-23 | Initiated | HSBC Securities | Hold |
| Jul-24-23 | Reiterated | Goldman | Buy |
| Jul-24-23 | Reiterated | Raymond James | Outperform |
| Jul-21-23 | Reiterated | Goldman | Buy |
| Jul-19-23 | Reiterated | Barclays | Overweight |
| Jul-19-23 | Reiterated | BofA Securities | Buy |
| Jul-19-23 | Reiterated | Mizuho | Buy |
| Jul-19-23 | Reiterated | TD Cowen | Outperform |
| Jul-19-23 | Reiterated | Wells Fargo | Overweight |
| Jul-17-23 | Reiterated | Mizuho | Buy |
| Jul-14-23 | Upgrade | UBS | Neutral → Buy |
| Jul-13-23 | Reiterated | Oppenheimer | Outperform |
| Apr-26-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Apr-26-23 | Reiterated | Goldman | Buy |
| Apr-26-23 | Reiterated | Guggenheim | Sell |
| Apr-26-23 | Reiterated | JP Morgan | Overweight |
| Apr-26-23 | Reiterated | Jefferies | Buy |
| Apr-26-23 | Upgrade | Macquarie | Neutral → Outperform |
| Apr-26-23 | Reiterated | Mizuho | Buy |
| Apr-26-23 | Reiterated | MoffettNathanson | Market Perform |
| Apr-26-23 | Reiterated | Morgan Stanley | Overweight |
| Apr-26-23 | Reiterated | Oppenheimer | Outperform |
| Apr-26-23 | Reiterated | Piper Sandler | Overweight |
| Apr-26-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-26-23 | Reiterated | Raymond James | Outperform |
| Apr-26-23 | Reiterated | Rosenblatt | Buy |
| Apr-26-23 | Reiterated | Stifel | Buy |
| Apr-26-23 | Reiterated | TD Cowen | Outperform |
| Apr-26-23 | Reiterated | UBS | Neutral |
| Apr-26-23 | Reiterated | Wedbush | Outperform |
| Apr-26-23 | Reiterated | Wells Fargo | Overweight |
| Apr-26-23 | Reiterated | Wolfe Research | Outperform |
| Apr-24-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Apr-21-23 | Reiterated | BMO Capital Markets | Market Perform |
| Apr-20-23 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Deutsche Bank | Buy |
| Jan-25-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-17-23 | Downgrade | Guggenheim | Neutral → Sell |
| Jan-05-23 | Initiated | DA Davidson | Buy |
| Jan-04-23 | Downgrade | UBS | Buy → Neutral |
| Nov-02-22 | Initiated | Macquarie | Neutral |
| Oct-14-22 | Reiterated | Morgan Stanley | Overweight |
| Sep-30-22 | Resumed | Raymond James | Outperform |
| Sep-22-22 | Initiated | MoffettNathanson | Hold |
| Aug-12-22 | Initiated | Guggenheim | Neutral |
| Jul-27-22 | Reiterated | BMO Capital Markets | Outperform |
| Jul-27-22 | Reiterated | Citigroup | Buy |
| Jul-27-22 | Reiterated | Cowen | Outperform |
| Jul-27-22 | Reiterated | Deutsche Bank | Buy |
| Jul-27-22 | Reiterated | Stifel | Buy |
| Jul-27-22 | Reiterated | Wedbush | Outperform |
| Jul-26-22 | Initiated | Itau BBA | Outperform |
| Jul-19-22 | Reiterated | Citigroup | Buy |
| Jun-29-22 | Initiated | Redburn | Buy |
| Apr-27-22 | Reiterated | BMO Capital Markets | Outperform |
| Apr-27-22 | Reiterated | Deutsche Bank | Buy |
| Apr-27-22 | Reiterated | Evercore ISI | In-line |
| Apr-27-22 | Reiterated | Stifel | Buy |
| Apr-27-22 | Reiterated | Wedbush | Outperform |
| Apr-27-22 | Reiterated | Wolfe Research | Outperform |
| Jan-26-22 | Reiterated | BMO Capital Markets | Outperform |
| Jan-26-22 | Reiterated | Citigroup | Buy |
| Jan-26-22 | Reiterated | Morgan Stanley | Overweight |
| Jan-26-22 | Reiterated | Oppenheimer | Outperform |
| Jan-12-22 | Reiterated | BMO Capital Markets | Outperform |
| Dec-22-21 | Initiated | SMBC Nikko | Outperform |
| Nov-22-21 | Initiated | Wells Fargo | Overweight |
| Nov-16-21 | Resumed | Credit Suisse | Outperform |
| Nov-02-21 | Initiated | Deutsche Bank | Buy |
| Oct-27-21 | Reiterated | Barclays | Overweight |
| Oct-27-21 | Reiterated | BofA Securities | Buy |
| Oct-27-21 | Reiterated | Cowen | Outperform |
| Oct-27-21 | Reiterated | Credit Suisse | Outperform |
| Oct-27-21 | Reiterated | Goldman | Buy |
| Oct-27-21 | Reiterated | Mizuho | Buy |
| Oct-27-21 | Reiterated | Morgan Stanley | Overweight |
| Oct-27-21 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-21 | Reiterated | Stifel | Buy |
| Sep-17-21 | Resumed | Rosenblatt | Buy |
| Sep-14-21 | Reiterated | Morgan Stanley | Overweight |
| Aug-20-21 | Reiterated | Mizuho | Buy |
| Jul-28-21 | Reiterated | Barclays | Overweight |
| Jul-28-21 | Reiterated | Bernstein | Outperform |
| Jul-28-21 | Reiterated | BofA Securities | Buy |
| Jul-28-21 | Reiterated | Citigroup | Buy |
| Jul-28-21 | Reiterated | Cowen | Outperform |
| Jul-28-21 | Reiterated | Credit Suisse | Outperform |
| Jul-28-21 | Reiterated | Griffin Securities | Buy |
| Jul-28-21 | Reiterated | Mizuho | Buy |
| Jul-28-21 | Reiterated | Morgan Stanley | Overweight |
| Jul-28-21 | Reiterated | Piper Sandler | Overweight |
| Jul-28-21 | Resumed | RBC Capital Mkts | Outperform |
| Jul-28-21 | Reiterated | Rosenblatt | Buy |
| Jul-28-21 | Reiterated | Stifel | Buy |
| Jul-28-21 | Reiterated | Wolfe Research | Outperform |
| Jul-22-21 | Reiterated | BofA Securities | Buy |
| Jul-22-21 | Reiterated | Citigroup | Buy |
| Jul-22-21 | Reiterated | Cowen | Outperform |
| Jul-22-21 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jun-23-21 | Reiterated | Wedbush | Outperform |
| May-13-21 | Initiated | Rosenblatt | Buy |
| Apr-23-21 | Initiated | Wolfe Research | Outperform |
| Apr-12-21 | Reiterated | BMO Capital Markets | Outperform |
| Apr-05-21 | Resumed | Credit Suisse | Outperform |
| Mar-16-21 | Resumed | Credit Suisse | Outperform |
| Mar-03-21 | Resumed | Citigroup | Buy |
| Jan-26-21 | Resumed | Raymond James | Strong Buy |
| Jan-22-21 | Initiated | Goldman | Buy |
| Dec-21-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-16-20 | Resumed | BofA Securities | Buy |
| Nov-24-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-14-20 | Resumed | UBS | Buy |
| Jul-23-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-20-20 | Reiterated | Stifel | Buy |
| Jul-15-20 | Reiterated | BMO Capital Markets | Outperform |
| Jul-09-20 | Reiterated | Wedbush | Outperform |
| Jun-24-20 | Reiterated | Argus | Buy |
| Jun-02-20 | Reiterated | Wells Fargo | Overweight |
| May-27-20 | Initiated | Summit Insights | Buy |
| Apr-30-20 | Reiterated | Griffin Securities | Buy |
| Jan-30-20 | Reiterated | Oppenheimer | Outperform |
| Jan-30-20 | Reiterated | Piper Sandler | Overweight |
| Jan-30-20 | Reiterated | RBC Capital Mkts | Outperform |
| Jan-30-20 | Reiterated | Raymond James | Strong Buy |
| Jan-30-20 | Reiterated | Stifel | Buy |
| Jan-30-20 | Reiterated | Wedbush | Outperform |
| Jan-30-20 | Reiterated | Wells Fargo | Overweight |
View All
Microsoft Corp Stock (MSFT) Latest News
Vanguard's Growth ETF Usually Beats the Market After a Lagging Year. I'd Own It, but Not for a 2027 Rebound. - The Motley Fool
Stock Market Today, Oct. 26: AI Optimism Lifts Nasdaq as Tech Stocks Rebound - The Motley Fool
Anthropic: The 5 Most Important Things Investors Need to Know from Its IPO Filing - The Motley Fool
Salesforce vs. International Business Machines: Which Technology Stock Is a Better Buy in 2026? - The Motley Fool
Not AMD. Not Marvell. Here's Which Company Nvidia Needs to Be Worried About. - The Motley Fool
Microsoft Stock Before Q1 Earnings: Buy Now or Wait for Results? - Zacks Investment Research
Warren Buffett's Favorite Stock Market Indicator Is Flashing Red. Here's What History Warns Is Coming Next. - The Motley Fool
Adobe vs. Datadog: Which Technology Stock Is a Better Buy in 2026? - The Motley Fool
Markets Await Mega Anthropic IPO - Zacks Investment Research
Adobe vs. Docusign: Which Technology Stock Is a Better Buy in 2026? - The Motley Fool
Anthropic IPO Coming, So Are "Mag 7" Q3 Reports - Zacks Investment Research
Micron Just Delivered a Monster Quarter, but the Stock Is Plummeting. The Reason Is Obvious. - The Motley Fool
1 Unstoppable Stock-Split Stock to Buy Before It Joins Nvidia, Alphabet, Microsoft, and Apple in the $3 Trillion Club - The Motley Fool
Should You Buy Amazon Before Oct. 29? - The Motley Fool
Is Goldman Sachs ActiveBeta World Equity ETF (GSWO) a Strong ETF Right Now? - Zacks Investment Research
Alphabet Has $514 Billion in Cloud Orders. Here’s What Matters More Than That Number on Oct. 28. - The Motley Fool
The Nasdaq Composite Just Plunged Almost 700 Points in One Day: Is a Stock Market Crash Imminent? - The Motley Fool
Microsoft, Alphabet, and Amazon Make Up About 15% of the S&P 500. All 3 Report Earnings Within 2 Days. - The Motley Fool
Vanguard S&P 500 ETF Long-Term Outlook: What Historical Trends Suggest for Patient Investors - The Motley Fool
Investors Are Worried About Too Much AI Spending. They're Not Wrong, But It's Paying Off for These 2 Tech Stocks. - The Motley Fool
Not Nvidia. Not Microsoft. This "Magnificent Seven" Stock Is the Cheapest Right Now. - The Motley Fool
If I Could Only Own 1 ETF for the Next 20 Years, Here's Exactly What I'd Pick and Why - The Motley Fool
History Says This ETF Could Be the Biggest Winner of the Stock Market Sell-Off - The Motley Fool
If the Stock Market Crashes, This Is the First ETF I'm Loading Up On - The Motley Fool
SI vs. AI: Super Intelligence Anomaly Outbreaks Trump’d by Clinton Legacy Tech (Veterans First for America) - GlobeNewswire Inc.
History Shows 1 Powerful Fact That Makes Me Bullish on VTI - The Motley Fool
Before You Buy the Vanguard S&P 500 ETF, There's 1 Sneaky Risk Investors Should Know - The Motley Fool
The Nasdaq Just Had Its Worst Day in 4 Months. Here's the Level That Would Signal a Correction, and What History Says Investors Can Do About It. - The Motley Fool
Stock Market Sell-Off: History Says This Is the Best Move to Make Right Now - The Motley Fool
Broadcom vs. Dell Technologies: Which Stock Is AI Powering to Be a Better Buy in 2026? - The Motley Fool
The Nasdaq-100 Had Its Worst Week in 18 Months. History Says the Following Year Has Usually Been Strong. - The Motley Fool
Vanguard Morningstar Growth ETF vs. Vanguard Information Technology ETF: Here's Which One I Believe Is the Clear Long-Term Winner. - The Motley Fool
The Puzzle Pieces for a Stock Market Crash Are Taking Shape, With 4 Historically Flawless Indicators Now Sounding the Alarm - The Motley Fool
Prediction: $200 a Month Invested in Nvidia Will Be Worth This Much by 2035 - The Motley Fool
3 Key Things to Monitor When Tech Giants Report Earnings - The Motley Fool
Billionaire Ken Griffin Says We May Be in a Bubble. Here’s What History Says Happens Next. - The Motley Fool
Here's the AI Chip Stock That Hedge Funds Are Loading Up On - The Motley Fool
SpaceX Burned More Than $9.9 Billion of Free Cash Flow in a Single Quarter. Here's How Long Its $85.7 Billion IPO War Chest Actually Lasts. - The Motley Fool
CoreWeave Is Down 13% in a Week. Here's the Price at Which I'd Buy - The Motley Fool
Q3 Earnings Season: Strong Base, Higher Revision Trends, and Promising 2027 Outlook - Zacks Investment Research
Not Intel. Not CoreWeave. This Underappreciated Nvidia-Backed Company Is Growing Artificial Intelligence (AI) Revenue by 123%. Here's Why It's a Buy Today for $8. - The Motley Fool
Constellation Energy vs. GE Vernova: Which Utilities Stock Is a Better Buy in 2026? - The Motley Fool
Salesforce vs. Snowflake: Which Technology Stock Is a Better Buy in 2026? - The Motley Fool
The Fidelity High Dividend ETF Is Near an All-Time High. Here's Why I'm Still Investing. - The Motley Fool
Pre-Q3 Earnings: Is Alphabet Stock a Portfolio Must-Have? - Zacks Investment Research
This Is the 1 ETF I'd Buy and Hold No Matter What the Market Does - The Motley Fool
Even With SOXX and DRAM Down Between 24% and 42% From Their Highs, I'd Still Rather Buy This Vanguard ETF for Semiconductor Stock Exposure - The Motley Fool
Copilot Readiness Assessments Help Regulated Organizations Check Sensitive File Access - GlobeNewswire Inc.
If a Stock Market Crash Is on the Way, Warren Buffett Says This Is the Best Thing Investors Can Do for Their Portfolio - The Motley Fool
The S&P 500 May Depend on the Fortunes of These 3 Companies Right Now. Here’s the Good News and the Bad News for Investors. - The Motley Fool
Microsoft Corp Stock (MSFT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Microsoft Corp Stock (MSFT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Amy Hood | EVP, Chief Financial Officer |
Sep 14 '26 |
Proposed Sale |
505.41 |
56,284 |
28,446,496 |
0 |
| Hood Amy | EVP, Chief Financial Officer |
Sep 14 '26 |
Sale |
498.27 |
41,674 |
20,764,845 |
533,624 |
| SATYA NADELLA | Director |
Sep 01 '26 |
Proposed Sale |
507.29 |
86,525 |
43,893,267 |
0 |
| Nadella Satya | Chief Executive Officer |
Sep 01 '26 |
Sale |
501.46 |
86,525 |
43,388,532 |
486,763 |
| Althoff Judson | Officer |
Aug 05 '26 |
Proposed Sale |
487.89 |
10,000 |
4,878,931 |
0 |
| Althoff Judson | CEO Microsoft Commercial |
Aug 05 '26 |
Sale |
487.89 |
10,000 |
4,878,930 |
100,447 |
| Numoto Takeshi | Officer |
Aug 04 '26 |
Proposed Sale |
487.65 |
6,444 |
3,142,417 |
0 |
| Numoto Takeshi | EVP, Chief Marketing Officer |
Aug 04 '26 |
Sale |
496.48 |
4,810 |
2,388,244 |
42,677 |
| Numoto Takeshi | EVP, Chief Marketing Officer |
Jun 10 '26 |
Sale |
402.84 |
4,500 |
1,812,780 |
47,468 |
| Numoto Takeshi | EVP, Chief Marketing Officer |
Jun 08 '26 |
Sale |
412.45 |
2,500 |
1,031,125 |
51,968 |
1.06%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):